ENLIVEN THERAPEUTICS INC - CONTINUES TO PREPARE FOR PHASE 3 TRIAL INITIATION IN 2026 AND THE COMMERCIALIZATION OF ELVN-001

Reuters · 5d ago

Please log in to view news